Back to
Ensign Peak Advisors, Inc
BBOT2 quarters
Position history for
Ensign Peak Advisors, Inc's holdings in BRIDGEBIO ONCOLOGY THERAPEUT
Ensign Peak Advisors, Inc holds 273,530 shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $2.1M as of 2026-Q2. The position was decreased (-14.8% shares). BBOT represents 0.0% of Ensign Peak Advisors, Inc's portfolio.
Current Value
$2.1M
Current Shares
273,530
Total Value Change
-$787,523
Total Shares Change
-47,344
Quarter-by-Quarter History
Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC